low pass WGS of patient from the CN300 cohort

Dataset ID Technology Samples
EGAD00001008800 Illumina NovaSeq 6000 603

Dataset Description

We copy number profiled 688 tumor regions from 300 patients presenting with advanced prostate cancer and prospectively followed-up (median, 7 years) in the control group of the STAMPEDE trial. Patients were categorised into four metastatic states, namely high-risk non-metastatic (with or without local lymph node involvement) or metastatic (low or high volume).

Who controls access to this dataset

For each dataset that requires controlled access, there is a corresponding Data Access Committee (DAC) who determine access permissions. Access to actual data files is not managed by the EGA. If you need to request access to this data set, please contact:

UCL cancer institute data access commitee
Contact person: Gert Attard
Email: g [dot] attard [at] ucl [dot] ac [dot] uk
More details: EGAC00001002659


You don't have access to the download section.